Rossland Pharmaceuticals Private Limited

Rossland Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74899DL1993PTC055676 Incorporated 18 October 1993 ROC Delhi HQ New Delhi, Delhi, India
Under Liquidation Private Limited Company pharma
Revenue · FY 2026
₹7.02 Lakh
▲ 14% YoY
Net profit · FY 2026
₹33,312
Net margin 4.7%
EBITDA · FY 2026
₹1.35 Lakh
EBITDA margin 19.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹4.9 Lakh
Issued & subscribed
Satisfied charges
₹8.21 Cr
No open charges
Company age
33 yrs
Est. 1993
Directors on board
2
As per MCA filings

About Rossland Pharmaceuticals Private Limited

Data last updated:

Rossland Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 October 1993.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1993PTC055676.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.9 Lakh. It is led by directors Jagdip Singh Binepal and Harpreet Binepal.

Its last annual general meeting (AGM) was held on 22 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at C – 35 Dda Sheds Okhla Phase – V, New Delhi, Delhi, India – 110020.

As per the financials filed for FY 2026, the company reported a revenue of ₹7.02 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹33,312 (net margin 4.7%) and EBITDA of ₹1.35 Lakh (EBITDA margin 19.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 18% over five years.

As per MCA filings, the company has satisfied charges of ₹8.21 Cr on record.

Company details

CIN U74899DL1993PTC055676
Registration Number 055676
Incorporation Date 18 October 1993
ROC Delhi
Listing Status Unlisted
Company Status Under Liquidation
Compliance Status Active Compliant

Contact details

Rossland Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    C – 35 Dda Sheds Okhla Phase – V, New Delhi, Delhi, India – 110020
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Rossland Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Rossland Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Rossland Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Rossland Pharmaceuticals Private Limited, buy the company report.

Financials of Rossland Pharmaceuticals Private Limited

FY 2026 filings available

Rossland Pharmaceuticals Private Limited reported revenue of ₹7.02 Lakh (up 14% YoY) for FY 2026.

Revenue · FY 2026
₹7.02 Lakh ▲ 14%
Net profit · FY 2026
₹33,312 margin 4.7%
EBITDA · FY 2026
₹1.35 Lakh margin 19.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 2%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 7%

Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 14% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹7.02 Lakh
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.35 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹33,312
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin19.2%
Net Profit Margin4.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Rossland Pharmaceuticals Private Limited, buy the company report.

Board of directors of Rossland Pharmaceuticals Private Limited

Rossland Pharmaceuticals has 2 directors on record. No former directors are listed.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Jagdip Singh BinepalDirector14 Aug 199531 Years 3 MonthsAs last reported
Harpreet BinepalDirector14 Aug 199531 Years 3 MonthsAs last reported

Auditor

Rossland Pharmaceuticals Private Limited is audited by S K GROVER & ASSOCIATES for the financial year 2021.

Auditor firmFinancial yearFirm registration number
S K GROVER & ASSOCIATESFY 2021005218N

Shareholding

The shareholding of Rossland Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Rossland Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹8.21 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹4.21 Cr
Syndicate Bank₹4.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
17 Mar 201110282589Hdfc Bank Limited₹4.21 CrSatisfied
29 Jan 200580001997Syndicate Bank₹1.05 CrSatisfied
06 Nov 200380001998Syndicate Bank₹2.94 CrSatisfied

To see the full charge records of Rossland Pharmaceuticals Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Rossland Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Rossland Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Rossland Pharmaceuticals Private Limited has 2 board changes on record since 1995: 2 appointments. The latest: Harpreet Binepal was appointed as Director on 14 Aug 1995.

AGM
Rossland Pharmaceuticals Private Limited last Annual general meeting of members was held on 22 Jun 2026 as per latest MCA records.
Filing
Rossland Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi I.
Charges
A charge registered on 17 Mar 2011 via Charge ID 10282589 with Hdfc Bank Limited was fully satisfied on 09 Aug 2012.
Charges
A charge registered on 29 Jan 2005 via Charge ID 80001997 with Syndicate Bank was fully satisfied on 08 Apr 2011.
Charges
A charge registered on 06 Nov 2003 via Charge ID 80001998 with Syndicate Bank was fully satisfied on 08 Apr 2011.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 421.00 Lakh with Charge ID 10282589 was registered on 17 Mar 2011.
Charges
A charge with Syndicate Bank of Rs. 294.48 Lakh registered on 06 Nov 2003 with Charge ID 80001998 was modified on 04 May 2010.
Charges
A charge with Syndicate Bank of Rs. 105.24 Lakh registered on 29 Jan 2005 with Charge ID 80001997 was modified on 16 Jun 2009.
Charges
A charge with Syndicate Bank amounted to Rs. 105.24 Lakh with Charge ID 80001997 was registered on 29 Jan 2005.
Charges
A charge with Syndicate Bank amounted to Rs. 294.48 Lakh with Charge ID 80001998 was registered on 06 Nov 2003.
Appointed
Harpreet Binepal was appointed as Director.
Appointed
Jagdip Singh Binepal was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Rossland Pharmaceuticals is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.

Rossland Pharmaceuticals is a company under liquidation, formerly operating as a private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 October 1993 and is registered under CIN U74899DL1993PTC055676. Caution is advised - the company may not have the legal capacity to fulfil new agreements.

Rossland Pharmaceuticals has 2 current directors:

The latest financial statements of Rossland Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 22 June 2026. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Rossland Pharmaceuticals is U74899DL1993PTC055676. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Rossland Pharmaceuticals has no open charges and satisfied charges of ₹8.21 Cr as per latest MCA filings.

Rossland Pharmaceuticals was incorporated on 18 October 1993. It is registered with the Registrar of Companies, Delhi.

Harpreet Binepal was appointed as Director on 14 Aug 1995. Jagdip Singh Binepal was appointed as Director on 14 Aug 1995.

The registered office of Rossland Pharmaceuticals is at C – 35 Dda Sheds Okhla Phase – V, New Delhi, Delhi, India – 110020.

Rossland Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.